Sign inGet started

Herrmann Ken

Insider CIK 2049757 · AKTS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AKTS Aktis Oncology, Inc. M Exercise deriv2026-07-202026-07-211,350— $018,364SEC↗
AKTS Aktis Oncology, Inc. M Exercise deriv2026-07-202026-07-213,506— $00SEC↗
AKTS Aktis Oncology, Inc. M Exercise2026-07-202026-07-213,506$0.08 $2803,506SEC↗
AKTS Aktis Oncology, Inc. M Exercise2026-07-202026-07-211,350$1.91 $2.6K4,856SEC↗
AKTS Aktis Oncology, Inc. S Sale2026-07-202026-07-213,506$24.56 $86.1K1,350SEC↗
AKTS Aktis Oncology, Inc. S Sale2026-07-202026-07-211,350$24.56 $33.2K0SEC↗
AKTS Aktis Oncology, Inc. M Exercise deriv2026-07-172026-07-203,065— $03,506SEC↗
AKTS Aktis Oncology, Inc. S Sale2026-07-172026-07-203,065$25.21 $77.3K0SEC↗
AKTS Aktis Oncology, Inc. M Exercise2026-07-172026-07-203,065$0.08 $2453,065SEC↗